We are live on ! Find out more
MME

Meag Munich Ergo Portfolio holdings

AUM $3.54B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+3.68%
1 Year Est. Return
+20%
3 Year Est. Return
+82.79%
5 Year Est. Return
+144.54%
10 Year Est. Return
+335.02%
AUM
$2.25B
AUM Growth
-$275M
Cap. Flow
-$263M
Cap. Flow %
-11.69%
Top 10 Hldgs %
19.26%
Holding
376
New
60
Increased
72
Reduced
83
Closed
94

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$43.1M
2
NOC icon
Northrop Grumman
NOC
+$41M
3
UNH icon
UnitedHealth
UNH
+$27.7M
4
MU icon
Micron Technology
MU
+$26.3M
5
T icon
AT&T
T
+$25.4M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$55.6M
2
CSCO icon
Cisco
CSCO
+$41.3M
3
IBM icon
IBM
IBM
+$34.6M
4
MDT icon
Medtronic
MDT
+$22.8M
5
PEG icon
Public Service Enterprise Group
PEG
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 16.69%
2 Healthcare 14.48%
3 Financials 12.72%
4 Industrials 10.51%
5 Consumer Staples 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCR
376
DELISTED
CR Bard Inc.
BCR
– –
-22,920
Closed -$5.68M
12 13 14 15
16

Similar funds

FHA
First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
MC
Martin Currie Edinburgh, United Kingdom $2.61B AUM 29.41% 1-Year Est. Return
CIA
ClearBridge Investments (Australia) Sydney, Australia $4.56B AUM 24.16% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
MD
Money Design Tokyo, Japan $2.14B AUM 10.33% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return

Meag Munich Ergo's Q2 2017 Portfolio in Review

As of Q2 2017, Meag Munich Ergo held 376 positions worth $2.25B, down 11% from $2.53B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Meag Munich Ergo withdrew a net $263M in Q2 2017, closing 94 positions and reducing 83 holdings. Its most notable exit was UBS Group, an estimated $55.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Meag Munich Ergo opened a new position in Northrop Grumman worth $4.69M.

  • Meag Munich Ergo's largest Q2 2017 buy was Northrop Grumman: 164,027 shares worth $4.69M.
  • Meag Munich Ergo added most to Labcorp in Q2 2017, an estimated $43.1M increase.
  • Meag Munich Ergo's biggest Q2 2017 reduction was Cisco, cutting an estimated $41.3M.
  • Meag Munich Ergo fully exited UBS Group in Q2 2017, selling an estimated $55.6M.
  • Meag Munich Ergo's ten largest holdings make up 19% of its $2.25B portfolio in Q2 2017.
  • Meag Munich Ergo opened 60 new positions and closed 94 in Q2 2017.
  • Meag Munich Ergo's portfolio value fell 11% quarter-over-quarter to $2.25B.

Based on Meag Munich Ergo's 13F filing for Q2 2017, filed 24 Jul 2017.